Paysign (NASDAQ:PAYS – Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, July 31st. Persons interested in participating in the company’s earnings conference call can do so using this link.
Paysign (NASDAQ:PAYS – Get Free Report) last released its earnings results on Tuesday, May 7th. The company reported $0.01 earnings per share (EPS) for the quarter. Paysign had a return on equity of 32.75% and a net margin of 13.77%. The company had revenue of $13.19 million for the quarter, compared to analyst estimates of $12.46 million. On average, analysts expect Paysign to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Paysign Stock Down 3.4 %
PAYS stock opened at $5.14 on Tuesday. Paysign has a 52 week low of $1.67 and a 52 week high of $5.55. The business has a 50-day simple moving average of $4.40 and a 200 day simple moving average of $3.90. The company has a market cap of $272.31 million, a PE ratio of 39.54 and a beta of 0.98.
Analysts Set New Price Targets
Read Our Latest Research Report on PAYS
Insider Transactions at Paysign
In related news, insider Matthew Louis Lanford sold 8,038 shares of the firm’s stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $4.03, for a total value of $32,393.14. Following the completion of the transaction, the insider now owns 100,431 shares in the company, valued at approximately $404,736.93. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 23.40% of the company’s stock.
Paysign Company Profile
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Read More
- Five stocks we like better than Paysign
- What Are the FAANG Stocks and Are They Good Investments?
- Survey: Top 175 Fittest Retirement Locations in America
- Following Congress Stock Trades
- Kimberly-Clark Stock Dips and a Buying Opportunity Emerges
- 3 Best Fintech Stocks for a Portfolio Boost
- Leading Gold Stock Shines With Q2 2024 Earnings Release
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.